GLP-1 Medications and Fertility: Dr. Sharron Manuel Featured in Endocrinology Advisor

Endocrinology Advisor recently published an article exploring how GLP‑1 medications, commonly used for diabetes and weight management, may impact fertility. The piece highlights how improving metabolic health can influence reproductive outcomes, particularly for patients with conditions like PCOS, where hormonal balance plays a key role in ovulation and conception.

HRC Fertility Pasadena physician Dr. Sharrón Manuel was featured in the article, offering her expert perspective on this emerging area of reproductive medicine. According to Dr. Manuel, GLP‑1 medications can have effects beyond blood sugar control, supporting hormonal balance and metabolic improvements that may, in some cases, enhance fertility when used appropriately as part of a comprehensive treatment plan.

The key takeaway? GLP‑1 medications are not fertility treatments, but understanding their metabolic effects — along with proper timing and guidance from a reproductive specialist — can help patients make informed decisions on their journey to parenthood. Dr. Manuel emphasizes the importance of personalized care, ensuring that each patient’s plan is tailored to their unique health profile and family-building goals. For anyone trying to conceive, this means knowing how medications, lifestyle, and overall health all play a role in reproductive success.

At HRC Fertility, we’re proud that our physicians like Dr. Manuel are helping patients navigate the latest developments in reproductive science. By combining expertise, research, and patient-centered guidance, we empower individuals and couples to make well-informed decisions at every stage of their fertility journey.

You can read the full article HERE.